��������

Petra Danielsohn-Weil is an accomplished professional with extensive experience in the pharmaceutical industry. Currently serving as a Member of the Supervisory Board at Grünenthal Group since January 2019, Danielsohn-Weil also held independent director positions at Invacare Corporation from May 2018 to May 2023 and at НоваМедика from September 2017 to March 2022. Previously, Danielsohn-Weil spent over eight years at Pfizer, where roles included Regional President for Europe, Russia, India, and Turkey, focusing on operational and P&L responsibilities across more than 55 markets, and Vice President of Strategy and Commercial Solutions, driving global strategy for emerging and established markets. Earlier managerial experience includes serving as CEO and Country Manager for Pfizer's Swiss operations and a Board member of pharmaceutical companies in Switzerland. Danielsohn-Weil holds a PhD in Biology, along with a Master’s in Chemistry and a Bachelor’s in Educational Psychology from the Universities of Wuerzburg, Berlin, and Muenster.